DK1061948T3 - Præparat til vedvarende frigivelse af et fysiologisk aktivt polypeptid samt fremstilling deraf - Google Patents

Præparat til vedvarende frigivelse af et fysiologisk aktivt polypeptid samt fremstilling deraf

Info

Publication number
DK1061948T3
DK1061948T3 DK99909234T DK99909234T DK1061948T3 DK 1061948 T3 DK1061948 T3 DK 1061948T3 DK 99909234 T DK99909234 T DK 99909234T DK 99909234 T DK99909234 T DK 99909234T DK 1061948 T3 DK1061948 T3 DK 1061948T3
Authority
DK
Denmark
Prior art keywords
preparation
polypeptide
physiologically active
sustained
active polypeptide
Prior art date
Application number
DK99909234T
Other languages
Danish (da)
English (en)
Inventor
Yutaka Yamagata
Masafumi Misaki
Susumu Iwasa
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DK1061948T3 publication Critical patent/DK1061948T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DK99909234T 1998-03-20 1999-03-18 Præparat til vedvarende frigivelse af et fysiologisk aktivt polypeptid samt fremstilling deraf DK1061948T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7185398 1998-03-20
PCT/JP1999/001359 WO1999048519A1 (en) 1998-03-20 1999-03-18 Sustained-release preparation of physiologically active polypeptide and production thereof

Publications (1)

Publication Number Publication Date
DK1061948T3 true DK1061948T3 (da) 2003-03-31

Family

ID=13472521

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99909234T DK1061948T3 (da) 1998-03-20 1999-03-18 Præparat til vedvarende frigivelse af et fysiologisk aktivt polypeptid samt fremstilling deraf

Country Status (12)

Country Link
US (1) US6482864B1 (de)
EP (1) EP1061948B1 (de)
KR (1) KR20010042079A (de)
CN (1) CN1301172A (de)
AT (1) ATE230274T1 (de)
AU (1) AU744354B2 (de)
BR (1) BR9908936A (de)
CA (1) CA2324568A1 (de)
DE (1) DE69904701T2 (de)
DK (1) DK1061948T3 (de)
WO (1) WO1999048519A1 (de)
ZA (1) ZA200004597B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2383144A1 (en) 1999-09-17 2001-03-29 Takeda Chemical Industries, Ltd. Process for producing protein powder
EP1346722B1 (de) 2000-12-01 2008-12-10 Takeda Pharmaceutical Company Limited Verfahren zur herstellung einer zubereitung mit einer bioaktiven substanz
US8637077B2 (en) * 2000-12-28 2014-01-28 Takeda Pharmaceutical Company Limited Sustained-release preparation
WO2002085399A1 (fr) * 2001-04-20 2002-10-31 Takeda Chemical Industries, Ltd. Preparations contenant un peptide
EP1413310A1 (de) * 2001-07-09 2004-04-28 Yamanouchi Pharmaceutical Co. Ltd. Zusammensetzungen mit verzögerter freisetzung zur injektion und verfahren zu ihrer herstellung
DE60315472T2 (de) * 2002-09-24 2008-04-30 Asahi Kasei Chemicals Corp. Glycolsaüre copolymer und verfahren zu dessen herstellung
CA2550695A1 (en) * 2003-12-16 2005-06-30 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R Glp-1 pharmaceutical compositions
US7582312B2 (en) 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
NZ565535A (en) * 2005-06-30 2011-03-31 Ipsen Pharma Sas GLP-1 pharmaceutical compositions
US20070004616A1 (en) * 2005-06-30 2007-01-04 Roland Cherif-Cheikh GLP-1 pharmaceutical compositions
US8071119B2 (en) 2007-05-14 2011-12-06 Sustained Nano Systems Llc Controlled release implantable dispensing device and method
US20080292680A1 (en) * 2007-05-14 2008-11-27 Sustained Nano Systems Llc Hypercompressed polymer particles for controlled release ophthalmic medications
WO2010123563A2 (en) * 2009-04-23 2010-10-28 Sustained Nano Systems Llc Controlled release dispensing device
CN102145160A (zh) * 2011-03-07 2011-08-10 深圳市健元医药科技有限公司 一种lhrh拮抗剂注射用的缓释植入制剂
CN102580056B (zh) * 2011-12-16 2014-04-09 深圳市健元医药科技有限公司 一种含抗利尿成分的缓释注射剂及其制备方法
CN113695370B (zh) * 2021-08-30 2022-06-07 河北科技大学 一种天然低共熔离子液体及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962091A (en) 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
DK0432232T3 (da) 1989-05-01 1994-01-31 Alkermes Inc Fremgangsmåde til fremstilling af små partikler af biologisk aktive molekyler
US5478564A (en) 1990-02-22 1995-12-26 Teva Pharmaceutical Industries, Ltd. Preparation of microparticles for controlled release of water-soluble substances
FR2658432B1 (fr) 1990-02-22 1994-07-01 Medgenix Group Sa Microspheres pour la liberation controlee des substances hydrosolubles et procede de preparation.
KR100225983B1 (ko) 1992-10-26 1999-10-15 클라우스-디터 홈메리히, 디트리히 빌헬름 샤흐트 마이크로캡슐의 제조 방법
DK0674506T3 (da) 1992-12-02 2001-01-08 Alkermes Inc Væksthormonholdige mikrosfærer med styret frigivelse
US6087324A (en) * 1993-06-24 2000-07-11 Takeda Chemical Industries, Ltd. Sustained-release preparation
NZ260909A (en) 1993-07-05 1995-04-27 Takeda Chemical Industries Ltd Production of sustained release preparation by allowing a water-soluble polypeptide to permeate into a biodegradable matrix in an aqueous solution
WO1997001331A2 (en) * 1995-06-27 1997-01-16 Takeda Chemical Industries, Ltd. Method of producing sustained-release preparation
EP0889722B1 (de) 1996-03-28 2002-11-20 Takeda Chemical Industries, Ltd. Zubereitung mit verzögerter freisetzung und deren herstellung
ZA9711385B (en) 1996-12-20 1999-06-18 Takeda Chemical Industries Ltd Method of producing a sustained-release preparation
US6287587B2 (en) 1997-07-15 2001-09-11 Takeda Chemical Industries, Ltd. Process for producing sustained-release preparation by in-water drying

Also Published As

Publication number Publication date
DE69904701T2 (de) 2003-11-06
ZA200004597B (en) 2002-02-27
BR9908936A (pt) 2005-10-25
AU2853399A (en) 1999-10-18
US6482864B1 (en) 2002-11-19
AU744354B2 (en) 2002-02-21
ATE230274T1 (de) 2003-01-15
EP1061948B1 (de) 2003-01-02
KR20010042079A (ko) 2001-05-25
CA2324568A1 (en) 1999-09-30
EP1061948A1 (de) 2000-12-27
DE69904701D1 (de) 2003-02-06
CN1301172A (zh) 2001-06-27
WO1999048519A1 (en) 1999-09-30

Similar Documents

Publication Publication Date Title
ATE230274T1 (de) Physiologisch aktives polypeptid enthaltende zubereitung mit verzögerter freisetzung und deren herstellung
DK0946169T3 (da) Fremgangsmåde til fremstilling af et præparat med vedvarende frigivelse
DK0862418T3 (da) Fremgangsmåde til fremstilling af morphologisk ensartede mikrokapsler såvel som mikrokapsler fremstillet efter denne fremgangsmåde
NO972608D0 (no) Opplösningshjelpemidler for hydrofile makromolekyler
DK0436370T3 (da) Farmaceutisk præparat til kontrolleret afgivelse og fremgangsmåde til fremstilling deraf
GR920100323A (el) Μία μέ?οδος παρασκευής μικροσφαιρίων αποτελούμενων από ένα βιοαποικοδομούμενο πολυμερικό υλικό.
ES2113371T3 (es) Transformacion de celulas epidermicas de tejidos animales con la ayuda de particulas.
BR0115730A (pt) materiais antimicrobianos foto-estabilizados
ATE184480T1 (de) Verfahren zur herstellung von arzneizubereitungen mit verzögerter wirkstoffabgabe
NO993709D0 (no) Stabilisert blanding omfattende fibrinogen
ATE110965T1 (de) Impfstoffe gegen hämophilus influenzae.
CA2076010A1 (fr) Microspheres, leur procede de preparation et leur utilisation
GB2314508A (en) Diamide-dicarboxylic acid microspheres
ES2076412T3 (es) Proceso para la fabricacion de microesferas.
EA200000154A1 (ru) Способ солюбилизации фармацевтически активных ингредиентов в воде и в водных носителях
CY1109207T1 (el) Διαδικασια εχινοκανδινης
EP1258254A4 (de) Zusammensetzungen zur verzögerten abgabe von physiologisch aktiven verbindungen die kaum wasserlösslich sind, verfahren zu deren herstellung und deren verwendung
ATE103976T1 (de) Verfahren zur verkapselung.
DE602004020632D1 (de) Verfahren zur herstellung einer alpha-1-antitrypsinlösung
HUP9801521A2 (hu) Javított tulajdonságú bevonatos peszticid hatású mátrixok, eljárás előállításukra és ilyeneket tartalmazó készítmények
DE50007153D1 (de) 3d-matrix zur herstellung von zelltransplantaten
ES2163038T3 (es) Procedimiento para la preparacion de clavulanato de potasio.
ES2185373T3 (es) Encapsulacion de peptidos solubles en agua.
DK0615746T3 (da) Vandigt liposomsystem og fremgangsmåde til fremstilling af et sådant liposomsystem
IE45285L (en) Polyribonucleotides.